Abstract
Studies have shown that 80-95% of pregnant patients who report a penicillin allergy can be safely de-labelled. A pencillin allergy has been associated with poor obstetric outcomes, low rates of appropriate antibiotic prescribing and additional healthcare system costs. In a cohort of patients in British Columbia, Canada, who underwent penicillin de-labelling in pregnancy we present safety data and calculations of the lifetime savings following de-labelling.
Full Text
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call